Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001193125-25-321152

Options or other derivatives

  • Director acquired 8,592 shares (grant or award)
  • Director returned 8,592 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

LAPORTE KATHLEEN · Director

Table II: Derivative

14 lines
Date Transaction Shares Owned after D/I
2025-12-12 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +1,392 1,392 D
2025-12-12 Returned to the company : show line 2 in the form Director Stock Option (Right to Buy) −1,392 0 D
2025-12-12 Grant or award : show line 3 in the form Director Stock Option (Right to Buy) +1,250 1,250 D
2025-12-12 Returned to the company : show line 4 in the form Director Stock Option (Right to Buy) −1,250 0 D
2025-12-12 Grant or award : show line 5 in the form Director Stock Option (Right to Buy) +1,250 1,250 D
2025-12-12 Returned to the company : show line 6 in the form Director Stock Option (Right to Buy) −1,250 0 D
2025-12-12 Grant or award : show line 7 in the form Director Stock Option (Right to Buy) +1,250 1,250 D
2025-12-12 Returned to the company : show line 8 in the form Director Stock Option (Right to Buy) −1,250 0 D
Loading xslF345X05/ownership.xml…